Tag: Novartis Pharmaceuticals Corporation

Home / Novartis Pharmaceuticals Corporation

Categories

Tisagenlecleucel is approved by FDA for relapsed or refractory follicular lymphoma

June 2022: After two or more lines of systemic therapy, the FDA awarded tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) expedited approval for adult patients with relapsed or refract...
novartis-pharmaceuticals-corporation

Scan the code